human genome picks up rights to cancer drug for $50
human genome sciences inc said it will develop and commercialize a privately held biotech firm's drug for multiple cancers in the united states, canada and european markets.
http://feeds.reuters.com/~r/reuters/healthnews/~3/g8rboezw41s/us-humangenome-idustre72f8od20110316
26496
16 Mar 2011 21:43:31
reuters
health